Meibomian Gland Dysfunction: Diagnosis, treatment, case management decisions
In this supplement, published by EuroTimes in association with the ESCRS Education Forum, experts share their perspectives on optimizing MGD diagnosis and treatment. The supplement includes insights from José M. Benitez del Castillo, Spain; José L. Güell, Spain; Francesco Carones, Italy; Jesper Hjortdal, Denmark; Béatrice Cochener-Lamard, France; and David Touboul, France.
The supplement is supported by an unrestricted medical educational grant from Alcon, Johnson & Johnson Vision and Novartis.
Download Supplement - click here
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.